SANGAMO THERAPEUTICS, INC Underwriting Agreements
6 Contracts & Agreements
- Underwriting Agreement, dated April 4, 2019, by and between Sangamo Therapeutics, Inc. and Cowen and Company, LLC, Wells Fargo Securities, LLC and Barclays Capital Inc., as... (Filed With SEC on April 4, 2019)
- Underwriting Agreement, dated April 25, 2018, by and between Sangamo Therapeutics, Inc. and Merrill Lynch Pierce, Fenner & Smith Incorporated, J.P. Morgan Securities LLC and Cowen... (Filed With SEC on April 26, 2018)
- 10,000,000 Shares SANGAMO THERAPEUTICS, INC. Common Stock, $0.01 par value UNDERWRITING AGREEMENT (Filed With SEC on June 21, 2017)
- 6,100,000 Shares of Common Stock par value $0.001 915,000 Over-Allotment Shares Sangamo BioSciences, Inc. UNDERWRITING AGREEMENT (Filed With SEC on September 18, 2013)
- 6,700,000 Shares Sangamo BioSciences, Inc. Common Stock UNDERWRITING AGREEMENT (Filed With SEC on April 11, 2011)
- 3,000,000 Shares Sangamo Biosciences, Inc. Common Stock UNDERWRITING AGREEMENT (Filed With SEC on October 13, 2009)